Nephrology Dialysis Transplantation, Vol 13, Issue 9 2271-2275, Copyright © 1998 by Oxford University Press
M Landt, D Brennan, C Parvin, K Flavin, S Dagogo-Jack and D Coyne
Background: Previous studies have reported that
patients with end-stage renal disease (ESRD) have elevated plasma leptin
concentrations, but the cause and significance of the elevations are
unknown. We studied leptin concentrations in 29 adults undergoing renal
transplantation, to determine if restoration of renal function reduced
leptin concentrations in ESRD. Methods: Leptin
concentrations were measured by radioimmunoassay in plasma specimens
collected within 1 week before transplant, 6 days post-transplant, and 60
days post-transplant. Results: Plasma letpin
concentrations were higher in both male and female ESRD patients compared
with a control population of similar age and body mass index (BMI), but
most of the disparity was due to a minority of patients with grossly
elevated concentrations; the majority of ESRD patients had normal or
near-normal leptin concentrations afer accounting for their adiposity with
BMI. Six days after successful renal transplantation, average plasma leptin
concentrations decreased to control levels. The grossly elevated
pretransplant concentrations in a minority of patients were greatly reduced
in relation to BMI, and the reduction persisted to 60 days post-transplant.
The decrease in creatinine with transplant did not correlate with the
decrease in leptin. Conclusions: These results
demonstrate that restoration of renal function in ESRD patients reduces
hyperleptinaemia, which provides further evidence of a cause/effect
relationship between impaired renal function and abnormal leptin
metabolism.
ORIGINAL ARTICLES
Hyperleptinaemia of end-stage renal disease is corrected by renal transplantation
Departments of Pediatrics, Internal Medicine and Pathology, Washington University School of Medicine, One Children's Place, St Louis, MO 63110, USA; Corresponding author
![]()
CiteULike
Connotea
Del.icio.us What's this?